AXGN

#2056
Axogen, Inc. Common Stock
34.4600 USD
+2.96%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
34.4600
34.4600
Rango anual
17.1400
35.9999
Cambio diario
+2.96%
Variación mensual
+5.03%
Variación en los últimos 6 meses
+88.93%
Cambio anual
+88.93%
Cierres anteriores
33.4700
Abrir
34.4600
Bid
Ask
Mínimo
34.4600
High
34.4600
Volumen
111
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 1.7884 B
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-96.26
Relación precio/flujo de caja
6.69

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Noticias